Evidence map›Paper›PMID 20859645›Full record

GuidelineClinical oral investigations2011

Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD.

Johannes K-H Meier, Daniel Wolff, Steve Pavletic, Hildegard Greinix, Martin Gosau, Hartmut Bertz, Stefanie J Lee, Anita Lawitschka, Sharon Elad, International Consensus Conference on Clinical Practice in cGVHD

Abstract readConsensus StatementPractice Guideline
PubMed Publisher
In one paragraph

Guideline in Clinical oral investigations, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 5 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 5 syntheses or guidelines pooled it, 80 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2012
    Guideline
  4. Guideline
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Oral Chronic Graft-Versus-Host Disease.Frontiers in oral health · 2022
    Review
  15. Recommendations for Therapeutic Apheresis by the Section "Preparative and Therapeutic Hemapheresis" of the German Society for Transfusion Medicine and Immunohematology.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2019
    Review
  16. Oral Complications of Chronic Graft-Versus-Host Disease.Journal of the National Cancer Institute. Monographs · 2019
    Review
  17. Review
  18. Unlocking the Complex Flavors of Dysgeusia after Hematopoietic Cell Transplantation.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2018
    Review
  19. Photobiomodulation therapy in the management of chronic oral graft-versus-host disease.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

Johannes K-H MeierDepartment of Cranio-Maxillo-Facial Surgery, University of Regensburg, Regensburg, Germany.
Daniel Wolff
Steve Pavletic
Hildegard Greinix
Martin Gosau
Hartmut Bertz
Stefanie J Lee
Anita Lawitschka
Sharon Elad
International Consensus Conference on Clinical Practice in cGVHD
University of Regensburg · DEBoston Children's Hospital · USFred Hutch Cancer Center · USHadassah · USMedical University of Vienna · ATNational Cancer Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic graft-versus-host disease (cGVHD) is a multi-organ disease that occurs post-hematopoietic stem cell transplantation, with the mouth being one of the most frequently affected organs. In 2009, the German-Austrian-Swiss working party on bone marrow and blood stem cell transplantation held a consensus conference to define clinical management of cGVHD. The consensus conference aimed to summarize the literature on diagnosis and topical treatment options for oral cGVHD and to provide recommendations for clinical practice, including routine dental and oral care as well as monitoring for secondary malignancies and bisphophonate-induced osteonecrosis of the jaw.

Indexed as

Administration, TopicalChronic DiseaseDental CariesEvidence-Based DentistryGlucocorticoidsGraft vs Host DiseaseHematopoietic Stem Cell TransplantationHumansImmunosuppressive AgentsJaw DiseasesMouth DiseasesMouth NeoplasmsNeoplasms, Second PrimaryOral Surgical ProceduresOsteonecrosisPeriodontal DiseasesGlucocorticoidsImmunosuppressive Agents

Identifiers

PMID20859645
OpenAlexW2006098739

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.